Search research articles
Contact Us
Filters
Showing results (701-710 of 863) with videos related to
Page
of 87
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
August 14, 2024
Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, et al.
Haematologica
|
October 13, 2004
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine
Caterina Borgna-Pignatti, Simone Rugolotto, Piero De Stefano, et al.
British Journal of Haematology
|
October 27, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial
Khaled M Musallam, Ali T Taher, John B Porter, et al.
Annals of the New York Academy of Sciences
|
December 13, 2005
Survival and complications in thalassemia
C Borgna-Pignatti, M D Cappellini, P De Stefano, et al.
American Journal of Hematology
|
November 6, 2018
Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO<sup>©</sup> )
Ali Taher, Maria Domenica Cappellini, Vip Viprakasit, et al.
Oncotarget
|
November 24, 2015
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB
Francesca Buontempo, Ester Orsini, Annalisa Lonetti, et al.
Recenti Progressi in Medicina
|
October 2, 2025
Towards learning healthcare systems in Italy: opportunities and challenges of AI at point-of-care
Luigi De Angelis, Alessio Pivetta, Francesco Baglivo, et al.
Haematologica
|
July 5, 2006
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
Antonio Piga, Renzo Galanello, Gian Luca Forni, et al.
Scientific Reports
|
February 23, 2012
Application and comparison of large-scale solution-based DNA capture-enrichment methods on ancient DNA
María C Avila-Arcos, Enrico Cappellini, J Alberto Romero-Navarro, et al.
British Journal of Haematology
|
May 30, 2012
Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years
Carla E M Hollak, Nadia Belmatoug, J Alexander Cole, et al.
Page
of 87
Search research articles
Search
Showing results (701-710 of 863) with videos related to
Sort By:
Page
of 87
Journal of Experimental & Clinical Cancer Research : CR
|
August 14, 2024
Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, et al.
Haematologica
|
October 13, 2004
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine
Caterina Borgna-Pignatti, Simone Rugolotto, Piero De Stefano, et al.
British Journal of Haematology
|
October 27, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial
Khaled M Musallam, Ali T Taher, John B Porter, et al.
Annals of the New York Academy of Sciences
|
December 13, 2005
Survival and complications in thalassemia
C Borgna-Pignatti, M D Cappellini, P De Stefano, et al.
American Journal of Hematology
|
November 6, 2018
Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO<sup>©</sup> )
Ali Taher, Maria Domenica Cappellini, Vip Viprakasit, et al.
Oncotarget
|
November 24, 2015
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB
Francesca Buontempo, Ester Orsini, Annalisa Lonetti, et al.
Recenti Progressi in Medicina
|
October 2, 2025
Towards learning healthcare systems in Italy: opportunities and challenges of AI at point-of-care
Luigi De Angelis, Alessio Pivetta, Francesco Baglivo, et al.
Haematologica
|
July 5, 2006
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
Antonio Piga, Renzo Galanello, Gian Luca Forni, et al.
Scientific Reports
|
February 23, 2012
Application and comparison of large-scale solution-based DNA capture-enrichment methods on ancient DNA
María C Avila-Arcos, Enrico Cappellini, J Alberto Romero-Navarro, et al.
British Journal of Haematology
|
May 30, 2012
Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years
Carla E M Hollak, Nadia Belmatoug, J Alexander Cole, et al.
Page
of 87